Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Language
Publication year range
1.
J Cell Biochem ; 107(6): 1083-96, 2009 Aug 15.
Article in English | MEDLINE | ID: mdl-19479899

ABSTRACT

The mechanisms of peroxisomal biogenesis remain incompletely understood, specially regarding the role of the endoplasmic reticulum (ER) in human cells, where genetic disorders of peroxisome biogenesis lead to Zellweger syndrome (ZS). The Pex3p peroxisomal membrane protein (PMP) required for early steps of peroxisome biogenesis has been detected in the ER in yeast but not in mammalian cells. Here, we show that Pex3p-GFP expressed in a new ZS cell line (MR), which lacks peroxisomes due to a mutation in the PEX3 gene, localizes first in the ER and subsequently in newly formed peroxisomes. Pex3p bearing an artificial N-glycosylation site shows an electrophoretic shift indicative of ER targeting while en route to preformed peroxisomes in normal fibroblast. A signal peptide that forces its entry into the ER does not eliminate its capability to drive peroxisome biogenesis in ZS cells. Thus, Pex3p is able to drive peroxisome biogenesis from the ER and its ER pathway is not privative of ZS cells. Cross-expression experiments of Pex3p in GM623 cells lacking Pex16p or Pex16p in MR cells lacking Pex3p, showed evidence that Pex3p requires Pex16p for ER location but is dispensable for the ER location of Pex16p. These results indicate that Pex3p follows the ER-to-peroxisomal route in mammalian cells and provides new clues to understand its function.


Subject(s)
Endoplasmic Reticulum/metabolism , Lipoproteins/physiology , Membrane Proteins/physiology , Peroxisomes/metabolism , Acyltransferases , Case-Control Studies , Catalase , Endoplasmic Reticulum/enzymology , Fibroblasts/cytology , Humans , Lipoproteins/genetics , Lipoproteins/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mutation , Peroxins , Protein Transport , Zellweger Syndrome
2.
Respir Physiol Neurobiol ; 164(3): 401-10, 2008 Dec 31.
Article in English | MEDLINE | ID: mdl-18824142

ABSTRACT

Histamine has been proposed to be an excitatory transmitter between the carotid body (CB) chemoreceptor (glomus) cells and petrosal ganglion (PG) neurons. The histamine biosynthetic pathway, its storage and release, as well as the presence of histamine H1, H2 and H3 receptors have been found in the CB. However, there is only indirect evidence showing the presence of histamine in glomus cells, or weather its application produces chemosensory excitation. Thus, we studied the histamine immunocytochemical localization in the cat CB, and the effects of histamine, and H1, H2 and H3 receptor blockers on carotid sinus nerve (CSN) discharge, using CB and PG preparations in vitro. We found histamine immunoreactivity in dense-cored vesicles of glomus cells. Histamine induced dose-dependent increases in CSN discharge in the CB, but not in the PG. The H1-antagonist pyrilamine reduced the CB responses induced by histamine, the H2-antagonists cimetidine and ranitidine had no effect, while the H3-antagonist thioperamide enhanced histamine-induced responses. Present data suggests that histamine plays an excitatory modulatory role in the generation of cat CB chemosensory activity.


Subject(s)
Carotid Body/cytology , Carotid Body/metabolism , Chemoreceptor Cells/metabolism , Histamine/metabolism , Acetylcholine/pharmacology , Action Potentials/drug effects , Animals , Cats , Chemoreceptor Cells/drug effects , Chemoreceptor Cells/ultrastructure , Dose-Response Relationship, Drug , Histamine/pharmacology , Histamine Agonists/pharmacology , Histamine H1 Antagonists/pharmacology , Histamine H3 Antagonists/pharmacology , Hypoxia/physiopathology , In Vitro Techniques , Male , Microscopy, Immunoelectron/methods , Nicotine/pharmacology , Nicotinic Agonists/pharmacology , Piperidines/pharmacology , Pyrilamine/pharmacology , Tyrosine 3-Monooxygenase/metabolism
3.
Exp Cell Res ; 304(1): 91-104, 2005 Mar 10.
Article in English | MEDLINE | ID: mdl-15707577

ABSTRACT

The molecular pathogenesis of Alzheimer's disease (AD) involves the participation of the amyloid-beta-peptide (A beta), which plays a critical role in the neurodegeneration that triggers the disease. Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors, which are members of the nuclear receptor family. We report here that (1) PPAR gamma is present in rat hippocampal neurons in culture. (2) Activation of PPAR gamma by troglitazone and rosiglitazone protects rat hippocampal neurons against A beta-induced neurodegeneration, as shown by the 3-[4,5 -2yl]-2,5-diphenyltetrazolium bromide (MTT) reduction assay, immunofluorescence using an anti-heavy neurofilament antibody, and quantitative electron microscopy. (3) Hippocampal neurons treated with several PPAR gamma agonists, including troglitazone, rosiglitazone, and ciglitazone, prevent the excitotoxic A beta-induced rise in bulk-free Ca2+. (4) PPAR gamma activation results in the modulation of Wnt signaling components, including the inhibition of glycogen synthase kinase-3beta (GSK-3beta) and an increase of the cytoplasmic and nuclear beta-catenin levels. We conclude that the activation of PPAR gamma prevents A beta-induced neurodegeneration by a mechanism that may involve a cross talk between neuronal PPAR gamma and the Wnt signaling pathway. More important, the fact that the activation of PPAR gamma attenuated A beta-dependent neurodegeneration opens the possibility to fight AD from a new therapeutic perspective.


Subject(s)
Amyloid beta-Peptides/toxicity , Hippocampus/metabolism , Intercellular Signaling Peptides and Proteins/physiology , Neurons/metabolism , PPAR gamma/metabolism , Signal Transduction , Animals , Chromans/pharmacology , Hippocampus/cytology , Humans , Neurons/drug effects , Neurons/ultrastructure , PPAR gamma/genetics , Rats , Thiazolidinediones/pharmacology , Troglitazone , Wnt Proteins
4.
Liver Transpl ; 9(11): 1199-210, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14586882

ABSTRACT

Hepatic ischemia-reperfusion (I-R) injury frequently is associated with cholestasis. However, the underlying mechanisms are not fully understood. The aim of the study is to assess bile secretory function in vivo in rats subjected to warm lobar hepatic ischemia at different times during reperfusion. A model of lobar 70% warm hepatic ischemia for 30 minutes was used with studies conducted at 1 and 6 hours and 1, 3, and 7 days after reperfusion. Bile secretory function was assessed after selective cannulation of bile ducts of ischemic (ILs) and nonischemic lobes (NILs). Serum activity of hepatic alanine and aspartate aminotransferase was slightly increased in rats subjected to I-R, whereas serum bile salt levels increased early during reperfusion, returning to control values after 7 days. ILs showed mild reversible leukocyte infiltration and no significant necrosis. Bile flow and bile salt excretion were significantly decreased in ILs during the first 24-hour reperfusion period compared with sham-operated rats and NILs. A marked reduction in glutathione (GSH) excretion occurred at 1 and 6 hours and 1 and 3 days, which returned to control values after 7 days. Total GSH and both reduced and oxidized GSH levels in liver homogenate and arterial blood GSH levels were unchanged at all times. Protein mass of multidrug resistance protein 2 and its function, assessed by the hepatic maximum secretory rate of ceftriaxone, did not show significant changes in ILs or NILs compared with sham-operated rats. Liver tissue gamma-glutamyl transpeptidase (GGT) and gamma-glutamylcysteine synthetase activities remained unchanged, whereas biliary GGT and cysteine secretory rates were significantly increased in ILs and NILs. Administration of acivicin, a GGT inhibitor, resulted in decreased secretion of this enzyme into bile and a parallel marked increase in biliary GSH secretion compared with untreated ischemic rats. In conclusion, warm hepatic I-R induces reversible cholestatic changes in ILs. GSH secretory rates from both ILs and NILs were markedly decreased during reperfusion. The reversibility of this effect after GGT inhibition, as well as increased release of active GGT into bile and cysteine biliary secretory rates, suggest increased GSH degradation in bile. These findings might be relevant for the I-R-induced clinical cholestasis, as well as cholangiocyte injury, seen after hepatic ischemia.


Subject(s)
Bile/metabolism , Liver/blood supply , Reperfusion Injury/physiopathology , Animals , Bile Acids and Salts/blood , Cholestasis/metabolism , Cholestasis/physiopathology , Cysteine/metabolism , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Glutamate-Cysteine Ligase/metabolism , Glutathione/blood , Isoxazoles/pharmacology , Liver/chemistry , Liver/pathology , Male , Mitochondrial Proteins/physiology , Rats , Rats, Sprague-Dawley , Reperfusion Injury/metabolism , Ribosomal Proteins/physiology , Saccharomyces cerevisiae Proteins/physiology
5.
Peptides ; 23(9): 1663-71, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12217427

ABSTRACT

Neuropeptide Y (NPY) and noradrenaline (NA) are co-transmitters at many sympathetic synapses, but it is not yet clear if their release is independently regulated. To address this question, we quantified the electrically evoked release of these co-transmitters from perivascular nerve terminals to the mesenteric circulation in control and drug-treated rats. 6-Hydroxydopamine reduced the tissue content and the electrically evoked release of ir-NPY and NA as well as the rise in perfusion pressure. A 0.001 mg/kg reserpine reduced the content of ir-NPY and NA, but did not modify their release nor altered the rise in perfusion pressure elicited by the electrical stimuli. However, 0.1mg/kg reserpine reduced both the content and release of NA but decreased only the content but not the release of ir-NPY; the rise in perfusion pressure was halved. Clonidine did not affect the release of ir-NPY while it lowered the outflow of NA, not altering the rise in perfusion pressure elicited by the electrical stimuli. Yohimbine, did not modify the release of ir-NPY but increased the NA outflow, it antagonized the clonidine effect. Therefore, presynaptic alpha2-adrenoceptors modulate the release of NA but not NPY, implying separate regulatory mechanisms.


Subject(s)
Neurons/metabolism , Neuropeptide Y/metabolism , Norepinephrine/metabolism , Receptors, Adrenergic, alpha-2/physiology , Acetylcholinesterase/metabolism , Animals , Clonidine/pharmacology , Dopamine beta-Hydroxylase/metabolism , Dose-Response Relationship, Drug , Immunohistochemistry , Microscopy, Fluorescence , Oxidopamine/metabolism , Rats , Rats, Sprague-Dawley , Reperfusion , Reserpine/pharmacology , Time Factors , Tissue Distribution , Yohimbine/pharmacology
6.
Biol. Res ; 27(1): 29-38, 1994. ilus
Article in English | LILACS | ID: lil-225967

ABSTRACT

The association of myosin and a filamin-like protein to the F-actin cytoskeleton of parietal cells was studied in the rat gastric mucosa. Myosin and the filamin-like protein were localized by indirect immunofluorescence microscopy while the distribution of actin was established by using FITC-phalloidin. These cytoskeletal proteins, concentrated in the parietal cells, changed their distribution in correlation with the hydrochloric acid (HCl) secretory state of the cells and the appearance of a developed intracellular canaliculus. Thus,in resting parietal cells, actin showed a patchy distribution, delimiting the poorly developed secretory canaliculi, while myosin and the filamin-like protein distributed diffusely over the cytoplasm. In secreting cells, F-actin was concentrated in the cytoplasmic projections filling the canalicular lumen, while myosin and the filamin-like protein were excluded from this region, concentrating in the adjoining cytoplasm. The present results show that myosin and the filamin-like protein change their association with the secretory membranes in relation to the development of the secretory canaliculus of parietal cells. In resting cells, both proteins associate with the endocellular secretory membranes. In secreting cells, the microvillar projections of the canalicular surface formed by these membranes bind F-actin, but exclude myosin and the filamin-like protein


Subject(s)
Animals , Rats , Actins/metabolism , Contractile Proteins/metabolism , Gastric Mucosa/ultrastructure , Microfilament Proteins/metabolism , Myosins/metabolism , Parietal Cells, Gastric/ultrastructure , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Contractile Proteins/ultrastructure , Cytoskeleton/metabolism , Cytoskeleton/ultrastructure , Fluorescent Antibody Technique , Gastric Acid/metabolism , Gastric Mucosa/ultrastructure , Microfilament Proteins/ultrastructure , Microscopy, Fluorescence , Myosins/ultrastructure , Parietal Cells, Gastric/metabolism , Rats, Sprague-Dawley
7.
Biol. Res ; 27(3/4): 177-92, 1994. ilus, graf
Article in English | LILACS | ID: lil-228577

ABSTRACT

The relation between the expression of the oxyntic cell phenotype and the modifications of the extracellular matrix during development of the gastric glands, was studied in 10 to 21 day-old chick embryos. Cytodifferentiation of the oxyntic cells was established by ultrastructural methods, while the expression of pepsinogen, mitochondrial enzyme markers and apical secretory membranes was determined by histochemical and biochemical procedures. Results show that the morphogenesis of the glandular lobules occurs between days 8 and 15 of gestation. Later on, the lobules enlarge but maintain their basic morphology. Until day 13, the developing glands consist of primary tubes lined by a stratified columnar epithelium. The apical poles of the cells that contact the lumen show cytoplasmic processes, and Mg-ATPase activity and F-actin are concentrated at the apical cell borders. From day 13 on, the cells of the simple epithelium that lines secondary tubules budding from the primary tube, show all the features that define differentiated oxyntic cells. The synthesis of glycosaminoglycans during glandular morphogenesis was studied measuring the incorporation of radioactive sulfate into developing chick embryo proventriculi. An important increase in isotope incorporation was found between days 13 and 18 of development. Histochemical localization of these macromolecules shows that glycosaminoglycans are closely associated with the developing glandular lobules. Variations in the structure of epithelial cells undergoing morphogenesis and in the composition of the extracellular matrix are synchronous, suggesting that interactions between them may be significant in terms of the establishment and maintenance of the adult gastric gland phenotype


Subject(s)
Animals , Chick Embryo , Extracellular Matrix , Gastric Mucosa/embryology , Parietal Cells, Gastric/cytology , Actins/analysis , Ca(2+) Mg(2+)-ATPase/analysis , Cell Differentiation , Electron Transport Complex IV/analysis , Gastric Mucosa/ultrastructure , Glycosaminoglycans/analysis , Morphogenesis
SELECTION OF CITATIONS
SEARCH DETAIL
...